Hélène Perrault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hélène Perrault has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jean Bourbeau
Respiratory Epidemiology and Clinical Research Unit of the Montreal Chest Institute, McGill University Health Center, Montreal, Quebec, Canada
2 shared publicationsAlain Cloutier
1 shared publicationAlain Delobbe
Clinique des maladies respiratoires, Hĵpital A. Calmette, CH et U, Lille, France
1 shared publicationAndré Davignon
1 shared publicationAshley Rycroft
Respiratory Epidemiology and Clinical Research Unit of the Montreal Chest Institute, McGill University Health Center, Montreal, Quebec, Canada
1 shared publicationBenoit Wallaert
1 shared publication
Latest Publications
- 1 January 2009
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6 (5) , 330-339
Paced-Walk and Step Tests to Assess Exertional Dyspnea in COPD
This study reports on the development and test-retest reproducibility of a modified shuttle walking and step testing protocols to assess exertional dyspnea in patients with COPD. Patients with COPD randomly performed four externally paced 3-min bouts of shuttle walking at 1.5, 2.5, 4.0 and 6.0 km·h− 1 or stepping at constant rate of 18, 22, 26 and 32 steps·min− 1. Walking and stepping procedures were repeated once, on a separate occasion. Ventilation, heart rate, gas exchange parameters and dyspnea Borg scores were obtained at the end of each exercise bout. Most patients completed walking or stepping at the slow and middle speed cadences but only 33% completed walking at 6.0 km·h− 1 and 40% completed stepping at 32 steps·min− 1. Walking and stepping at progressively faster pace caused a progressive increase in ventilation and dyspnea. Test-retest Pearson correlation coefficients for ventilation, heart rate, gas exchange parameters and dyspnea scores over the four exercise bouts, all exceeded 0.80. Intra-class correlation coefficients were at least as strong as Pearson coefficients. Bland & Altman representation showed that for repeated Borg scores, 92 and 96% of points lied within 2 SD of the mean difference between test-retest values for walking and stepping. The majority of moderate and severe COPD patients completed the 3-min shuttle waking testing at 1.5 to 4.0 km·h− 1 and the 3-min of step testing at rates between 18 and 26 steps·min− 1. Both field tests were highly reproducible in patients with COPD.
- 1 January 2009
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6 (5) , 330-339
Paced-Walk and Step Tests to Assess Exertional Dyspnea in COPD
This study reports on the development and test-retest reproducibility of a modified shuttle walking and step testing protocols to assess exertional dyspnea in patients with COPD. Patients with COPD randomly performed four externally paced 3-min bouts of shuttle walking at 1.5, 2.5, 4.0 and 6.0 km·h− 1 or stepping at constant rate of 18, 22, 26 and 32 steps·min− 1. Walking and stepping procedures were repeated once, on a separate occasion. Ventilation, heart rate, gas exchange parameters and dyspnea Borg scores were obtained at the end of each exercise bout. Most patients completed walking or stepping at the slow and middle speed cadences but only 33% completed walking at 6.0 km·h− 1 and 40% completed stepping at 32 steps·min− 1. Walking and stepping at progressively faster pace caused a progressive increase in ventilation and dyspnea. Test-retest Pearson correlation coefficients for ventilation, heart rate, gas exchange parameters and dyspnea scores over the four exercise bouts, all exceeded 0.80. Intra-class correlation coefficients were at least as strong as Pearson coefficients. Bland & Altman representation showed that for repeated Borg scores, 92 and 96% of points lied within 2 SD of the mean difference between test-retest values for walking and stepping. The majority of moderate and severe COPD patients completed the 3-min shuttle waking testing at 1.5 to 4.0 km·h− 1 and the 3-min of step testing at rates between 18 and 26 steps·min− 1. Both field tests were highly reproducible in patients with COPD.
- 1 June 2007
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 39 (6) , 918-925
Cycling Efficiency Is Not Compromised for Moderate Exercise in Moderately Severe COPD
And external work of cycling and delta mechanical efficiency in 40 patients (FEV1: 36 ± 14% predicted) with COPD and 28 healthy age-matched controls while characterizing dynamic hyperinflation. Methods: Steady-state V˙O2 was obtained at rest, during unloaded and 20-W cycling, and at 20, 50, and 65% peak cycling power. Delta mechanical efficiency was calculated between constant-load cycling at 65 and 20% peak power. Dynamic hyperinflation was assessed from inspiratory capacity maneuvers. Results: Oxygen demands (L·min−1) at rest, for internal work (0.47 ± 0.14 vs 0.45 ± 0.11) or external work at 20 W (0.62 ± 0.20 vs 0.57 ± 0.13), were not different between patients and controls, although ventilation was elevated in COPD. Cycling at 65% of peak power induced dynamic hyperinflation in COPD, which indices were not related to cycling efficiency. Delta efficiency (%) was not different between patients (26.3 ± 8.1) and controls (24.8 ± 4.0). Conclusion: Findings suggest that bioenergetics of submaximal cycling is not compromised in moderately severe COPD despite tachypnea and dynamic hyperinflation....
- 1 June 2007
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 39 (6) , 918-925
Cycling Efficiency Is Not Compromised for Moderate Exercise in Moderately Severe COPD
And external work of cycling and delta mechanical efficiency in 40 patients (FEV1: 36 ± 14% predicted) with COPD and 28 healthy age-matched controls while characterizing dynamic hyperinflation. Methods: Steady-state V˙O2 was obtained at rest, during unloaded and 20-W cycling, and at 20, 50, and 65% peak cycling power. Delta mechanical efficiency was calculated between constant-load cycling at 65 and 20% peak power. Dynamic hyperinflation was assessed from inspiratory capacity maneuvers. Results: Oxygen demands (L·min−1) at rest, for internal work (0.47 ± 0.14 vs 0.45 ± 0.11) or external work at 20 W (0.62 ± 0.20 vs 0.57 ± 0.13), were not different between patients and controls, although ventilation was elevated in COPD. Cycling at 65% of peak power induced dynamic hyperinflation in COPD, which indices were not related to cycling efficiency. Delta efficiency (%) was not different between patients (26.3 ± 8.1) and controls (24.8 ± 4.0). Conclusion: Findings suggest that bioenergetics of submaximal cycling is not compromised in moderately severe COPD despite tachypnea and dynamic hyperinflation....
- 1 April 2006
- Vol. 29 (2) , 117-21
Efficiency of movement in health and chronic disease.
Mechanical efficiency of movement expresses the efficacy of skeletal muscles to transform biochemical energy into "external work" or movement. In young healthy humans, the mechanical efficiency and/or the work economy of various locomotor activities such as cycling, up-hill walking or running, stair climbing or swimming varies from 5 - 9% for swimming to 20-25% for cycling ergometry or stair climbing. There are five potential steps at which an extra demand or "wasting" of energy may occur in supplying energy to the contracting muscle: a) the resting metabolism b) the cost of ventilation b) the percentage of moles of ATP produced per mole of atomic oxygen processed through the mitochondria c) the percentage of molecular ATP used by myofibrils for tension production and d) the cost of multi-segment movement coordination towards a locomotor displacement. This article presents the little evidence available on the efficiency of movement in patients with chronic diseases such as COPD and discusses the mechanisms through which chronic disease may contribute to a potential "exaggerated energy demand" or "energy wastage".
- 1 April 2006
- Vol. 29 (2) , 117-21
Efficiency of movement in health and chronic disease.
Mechanical efficiency of movement expresses the efficacy of skeletal muscles to transform biochemical energy into "external work" or movement. In young healthy humans, the mechanical efficiency and/or the work economy of various locomotor activities such as cycling, up-hill walking or running, stair climbing or swimming varies from 5 - 9% for swimming to 20-25% for cycling ergometry or stair climbing. There are five potential steps at which an extra demand or "wasting" of energy may occur in supplying energy to the contracting muscle: a) the resting metabolism b) the cost of ventilation b) the percentage of moles of ATP produced per mole of atomic oxygen processed through the mitochondria c) the percentage of molecular ATP used by myofibrils for tension production and d) the cost of multi-segment movement coordination towards a locomotor displacement. This article presents the little evidence available on the efficiency of movement in patients with chronic diseases such as COPD and discusses the mechanisms through which chronic disease may contribute to a potential "exaggerated energy demand" or "energy wastage".
- 1 February 2003
- Vol. 19 (2) , 145-50
Baroreflex resetting after successful surgical repair of tetralogy of Fallot.
Tetralogy of Fallot (TOF) and its surgical repair are associated with alterations in right ventricular systolic and diastolic functions. The cardiopulmonary baroreflex describes the peripheral vasoconstriction response to the volume-unloading deactivation of left and possibly right ventricular receptors. Alterations in cardiac geometry or distensibility and pulmonary vasculature of operated TOF may affect the mechanical stimulation of sensitive cardiopulmonary receptors leading to an impaired baroreflex function. There has to date been no report on the integrity of baroreflex function in postoperative TOF. To characterize the combined cardiopulmonary and baroreflex response of patients successfully operated for TOF in early childhood to central volume unloading using graded lower body negative pressure (LBNP) application. Fifteen patients operated on for TOF (mean+/-SEM) 15.7+/-1.4 years previously and 13 healthy age-matched control subjects were submitted to four consecutive 5 min LBNP applications at -10, -20, -30 and -40 mmHg. Forearm blood flow and vascular resistance, left ventricle end-diastolic diameter (LVEDD), arterial blood pressure and heart rate were obtained. TOF exhibited a lower LVEDD (42.7+/-1.5 mm) than control subjects (51.9+/-1.6). The forearm vascular resistance to LVEDD relationship was shifted left and upward in TOF compared with that of control subjects, but the slope of the relationship was not different between groups. LBNP -40 mmHg induced a lesser change in heart rate in TOF (+10.6+/-1.5%) than in control subjects (+14.7 +/-2.4%) and an increase (P<0.05) in diastolic blood pressure in TOF (-2.4+/-2.5%), which was not seen in control subjects (+4.3+/-2.9%). Young adults successfully operated on for TOF in early childhood exhibit a resetting of the cardiopulmonary baroreflex to operate at smaller LVEDD and at a higher level of forearm vascular resistance. The blunted heart rate response to LBNP -40 mmHg is consistent with previous observations pointing to disturbances in the efferent arm of the baroreflex.
- 1 February 2003
- Vol. 19 (2) , 145-50
Baroreflex resetting after successful surgical repair of tetralogy of Fallot.
Tetralogy of Fallot (TOF) and its surgical repair are associated with alterations in right ventricular systolic and diastolic functions. The cardiopulmonary baroreflex describes the peripheral vasoconstriction response to the volume-unloading deactivation of left and possibly right ventricular receptors. Alterations in cardiac geometry or distensibility and pulmonary vasculature of operated TOF may affect the mechanical stimulation of sensitive cardiopulmonary receptors leading to an impaired baroreflex function. There has to date been no report on the integrity of baroreflex function in postoperative TOF. To characterize the combined cardiopulmonary and baroreflex response of patients successfully operated for TOF in early childhood to central volume unloading using graded lower body negative pressure (LBNP) application. Fifteen patients operated on for TOF (mean+/-SEM) 15.7+/-1.4 years previously and 13 healthy age-matched control subjects were submitted to four consecutive 5 min LBNP applications at -10, -20, -30 and -40 mmHg. Forearm blood flow and vascular resistance, left ventricle end-diastolic diameter (LVEDD), arterial blood pressure and heart rate were obtained. TOF exhibited a lower LVEDD (42.7+/-1.5 mm) than control subjects (51.9+/-1.6). The forearm vascular resistance to LVEDD relationship was shifted left and upward in TOF compared with that of control subjects, but the slope of the relationship was not different between groups. LBNP -40 mmHg induced a lesser change in heart rate in TOF (+10.6+/-1.5%) than in control subjects (+14.7 +/-2.4%) and an increase (P<0.05) in diastolic blood pressure in TOF (-2.4+/-2.5%), which was not seen in control subjects (+4.3+/-2.9%). Young adults successfully operated on for TOF in early childhood exhibit a resetting of the cardiopulmonary baroreflex to operate at smaller LVEDD and at a higher level of forearm vascular resistance. The blunted heart rate response to LBNP -40 mmHg is consistent with previous observations pointing to disturbances in the efferent arm of the baroreflex.
- 1 June 2002
- Vol. 19 (2) , 148-53
Impaired exercise response in sarcoid patients with normal pulmonary functio.
Sarcoidosis is a granulomatous disease with frequent pul monary involvement. Patients generally exhibit a 25-30% reduction in maximal aerobic capacit (VO2max). As most investigations have included patients with both normal and abnormal resting pulmonary function tests (PFT), the mechanisms responsible for this limitation remain unclear. We initiated a prospective study to characterize the cardio-respiratory response to exercise in sarcoid patients with normal resting PFT. 19 untreated male patients with biopsy-proven sarcoidosis and 19 age- an sex-matched sedentary healthy controls (38 +/- 8.7 vs 37 +/- 8.7 yrs ; Body Mass Index: 24 +/- 3.05 vs 23 +/- 3.05) were included in the study. All patients had normal resting PFT including diffusing capacity for CO (DLCO) > 80% predicted and normal cardiac status at rest as assessed by EKG and echocardiography. A maximal cycling test was performed in all subjects. True maximal effort was obtaine in all subjects (plasma lactate 9.1 +/- 2.6 vs 11.0 +/- 2.2 mmol l(-1), pH 7.35 +/- 0.04 vs 7.34 +/- 0.04) (patients vs controls). Patients exhibited a 30% lower maximal workload and/or VO2max (2,128 +/- 413 vs 2,909 +/- 387 ml x min(-1)) than controls. Maximal ventilation (79 +/- 21.7 vs 110 +/- 21.7 l x min(-1)) and tital volume (VT) (2,313 +/- 517 ml vs 2,856 +/- 339) were significantly lower in patients than in controls while dead space t tital volume ratio (VD/V(T)) (0.18 +/- 0.09 vs 0.11 +/- 0.04) was higher in patients than in controls. PaO2, PAiO2, and PAi-aO2 at VO2max were not significantly different between patient and controls. Peak exercise EKG was normal in all but one patient. Interestingly, heart rate was significantly lower in patients for all relative exercise intensities > or = 60% VO2max including maximum (159 +/- 21.7 vs 182 +/- 13) The present observations indicate a significant maximal exercise limitation in sarcoid patients without significant pulmonary impairment which could be related at least in part to an impaired heart rate response to exercise.
- 1 June 2002
- Vol. 19 (2) , 148-53
Impaired exercise response in sarcoid patients with normal pulmonary functio.
Sarcoidosis is a granulomatous disease with frequent pul monary involvement. Patients generally exhibit a 25-30% reduction in maximal aerobic capacit (VO2max). As most investigations have included patients with both normal and abnormal resting pulmonary function tests (PFT), the mechanisms responsible for this limitation remain unclear. We initiated a prospective study to characterize the cardio-respiratory response to exercise in sarcoid patients with normal resting PFT. 19 untreated male patients with biopsy-proven sarcoidosis and 19 age- an sex-matched sedentary healthy controls (38 +/- 8.7 vs 37 +/- 8.7 yrs ; Body Mass Index: 24 +/- 3.05 vs 23 +/- 3.05) were included in the study. All patients had normal resting PFT including diffusing capacity for CO (DLCO) > 80% predicted and normal cardiac status at rest as assessed by EKG and echocardiography. A maximal cycling test was performed in all subjects. True maximal effort was obtaine in all subjects (plasma lactate 9.1 +/- 2.6 vs 11.0 +/- 2.2 mmol l(-1), pH 7.35 +/- 0.04 vs 7.34 +/- 0.04) (patients vs controls). Patients exhibited a 30% lower maximal workload and/or VO2max (2,128 +/- 413 vs 2,909 +/- 387 ml x min(-1)) than controls. Maximal ventilation (79 +/- 21.7 vs 110 +/- 21.7 l x min(-1)) and tital volume (VT) (2,313 +/- 517 ml vs 2,856 +/- 339) were significantly lower in patients than in controls while dead space t tital volume ratio (VD/V(T)) (0.18 +/- 0.09 vs 0.11 +/- 0.04) was higher in patients than in controls. PaO2, PAiO2, and PAi-aO2 at VO2max were not significantly different between patient and controls. Peak exercise EKG was normal in all but one patient. Interestingly, heart rate was significantly lower in patients for all relative exercise intensities > or = 60% VO2max including maximum (159 +/- 21.7 vs 182 +/- 13) The present observations indicate a significant maximal exercise limitation in sarcoid patients without significant pulmonary impairment which could be related at least in part to an impaired heart rate response to exercise.